NSEAcquisition25 Jun 2026 · 25 Jun 2026, 06:41 pm
Acquisition
Aurobindo Pharma Limited · AUROPHARMA
✦ AI Summaryacquisition
Aurobindo Pharma Limited has informed the Exchange about the completion of the execution of a solar power purchase agreement and acquired a 26% stake in Swarnaakshu Solar Power Private Limited.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aurobindo Pharma Limited has informed the Exchange about Acquisition
Attachments (1)
📄pdf
Download →
AUROPHARMA_25062026184115_LtrToSEsUpdateSwarnakshu25062026.pdf
View document text
June 25, 2026
To To
Listing Department, The Corporate Relations Department
NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED
Exchange Plaza, Phiroz Jeejeebhoy Towers,
Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street,
MUMBAI -400 051 MUMBAI -400 001
Company Code No. AUROPHARMA Company Code No. 524804
Dear Sir / Madam,
Sub: Completion of execution of solar power purchase agreement and acquired 26% stake in Swarnaakshu
Solar Power Private Limited.
Ref : Our letters dated February 6, 2025, March 28, 2025, June 30, 2025, September 26, 2025, December 30,
2025 and March 30, 2026.
This has reference to aforementioned letters whereby Company informed about the execution of power
purchase agreement with Swarnaakshu Solar Power Private Limited (Swarnaakshu), for purchase of solar power
under the captive power policy of the Government of Telangana and investment up to Rs.10.40 crores for
acquiring 26% of the paid up equity share capital and other securities of Swarnaakshu.
In this regard, this is to inform that the Company has today i.e., June 25, 2026, made the initial investment of Rs.
52 lakhs and acquired 26% equity share capital of Swarnaakshu and also entered into a power purchase
agreement with Swarnaakshu to purchase solar power for captive consumption. The balance investment will be
made from time to time depending upon the progress of the solar project and fund requirements of
Swarnaakshu.
Please take the information on record.
Yours faithfully,
For AUROBINDO PHARMA LIMITED
B. Adi Reddy
Company Secretary
Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India.
Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044.
Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038, Telangana, India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833
Email: info@aurobindo.com Website: www.aurobindo.com